Inflammatory breast cancer (IBC) is characterized by NF‐κB activation, which causes endoplasmic reticulum (ER) downregulation, overexpression of EGFR and ErbB2, and hyperactivation of MAPK.167. The gene discussed is NFKB1; the disease is inflammatory breast carcinoma.